Months before drug launch, this Peninsula company drew people to get its sweat stopper

Months before winning regulatory approval of its drug against excessive sweating — and nearly a year ahead of the drug's expected launch next month — Dermira Inc. targeted potential users of the drug. In a series of online ads that started in December, followed by television ads in June, the Menlo Park company laid out the pathology of a condition that affects some 15 milli on Americans who produce more underarm sweat than necessary to control their body temperature. In one ad, a young woman…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news